News
12-21-2019, 09:26 PM
Diagnostics company SphingoTec GmbH today reported on the publication of novel study results of its proprietary kidney function biomarker penKid® in BMC Emergency Medicine.
More... (https://www.news-medical.net/news/20191221/Sphingotecs-penKid-is-a-reliable-marker-for-detection-and-monitoring-of-acute-kidney-injury.aspx)
More... (https://www.news-medical.net/news/20191221/Sphingotecs-penKid-is-a-reliable-marker-for-detection-and-monitoring-of-acute-kidney-injury.aspx)